{"id":"https://openalex.org/W4294127964","doi":null,"title":"[68Ga-DOTATOC PET/CT for Diagnosing Neuroendocrine Tumors].","display_name":"[68Ga-DOTATOC PET/CT for Diagnosing Neuroendocrine Tumors].","alternate_titles":[],"publication_year":2022,"publication_date":"2022-08-01","ids":{"openalex":"https://openalex.org/W4294127964","pmid":"https://pubmed.ncbi.nlm.nih.gov/36046963"},"language":"ja","primary_location":{"id":"pmid:36046963","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36046963","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W4294127964"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085956105","display_name":"Sho Koyasu","orcid":"https://orcid.org/0000-0002-6690-7460","observed_orcids":["https://orcid.org/0000-0002-6690-7460"]},"institutions":[{"id":"https://openalex.org/I22299242","display_name":"Kyoto University","ror":"https://ror.org/02kpeqv85","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sho Koyasu","raw_affiliation_strings":["Dept. of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University","institution_ids":["https://openalex.org/I22299242"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yoichi Shimizu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoichi Shimizu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5043250653","display_name":"Yuji Nakamoto","orcid":"https://orcid.org/0000-0001-5783-8048","observed_orcids":["https://orcid.org/0000-0001-5783-8048"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yuji Nakamoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1008,"has_fulltext":false,"cited_by_count":1,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.31356366,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"49","issue":"8","first_page":"821","last_page":"825"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/68ga-dotatoc-pet-ct","display_name":"68Ga-DOTATOC PET/CT","score":0.9110000133514404},{"id":"https://openalex.org/keywords/neuroendocrine-tumors","display_name":"neuroendocrine tumors","score":0.9599999785423279},{"id":"https://openalex.org/keywords/somatostatin-receptor-positive-tumors","display_name":"somatostatin receptor-positive tumors","score":0.8379999995231628},{"id":"https://openalex.org/keywords/peptide-receptor-radionuclide-therapy","display_name":"peptide receptor radionuclide therapy","score":0.8859999775886536},{"id":"https://openalex.org/keywords/177lu-dotatate","display_name":"177Lu-DOTATATE","score":0.9629999995231628},{"id":"https://openalex.org/keywords/somatostatin-analogs","display_name":"somatostatin analogues","score":0.8820000290870667},{"id":"https://openalex.org/keywords/somatostatin-receptor-imaging","display_name":"somatostatin receptor imaging","score":0.8050000071525574}],"concepts":[{"id":"https://openalex.org/C80115893","wikidata":"https://www.wikidata.org/wiki/Q2067077","display_name":"Somatostatin receptor","level":3,"score":0.8810802698135376},{"id":"https://openalex.org/C2993559085","wikidata":"https://www.wikidata.org/wiki/Q2126444","display_name":"Radionuclide therapy","level":2,"score":0.833198070526123},{"id":"https://openalex.org/C2779066768","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine tumors","level":2,"score":0.8242464065551758},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7539693713188171},{"id":"https://openalex.org/C3017732841","wikidata":"https://www.wikidata.org/wiki/Q25098597","display_name":"Peptide receptor","level":3,"score":0.7207002639770508},{"id":"https://openalex.org/C2776297358","wikidata":"https://www.wikidata.org/wiki/Q407166","display_name":"Somatostatin","level":2,"score":0.5849863290786743},{"id":"https://openalex.org/C2910487530","wikidata":"https://www.wikidata.org/wiki/Q407166","display_name":"Somatostatin Analogue","level":4,"score":0.5500088334083557},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.4962628483772278},{"id":"https://openalex.org/C2779902710","wikidata":"https://www.wikidata.org/wiki/Q1130465","display_name":"Scintigraphy","level":2,"score":0.4957912862300873},{"id":"https://openalex.org/C2781025020","wikidata":"https://www.wikidata.org/wiki/Q419935","display_name":"Octreotide","level":3,"score":0.48135262727737427},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3701673746109009},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3453577160835266},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.31679290533065796}],"mesh":[{"descriptor_ui":"D000072078","descriptor_name":"Positron Emission Tomography Computed Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009942","descriptor_name":"Organometallic Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015282","descriptor_name":"Octreotide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D015282","descriptor_name":"Octreotide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018358","descriptor_name":"Neuroendocrine Tumors","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:36046963","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36046963","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3127485250","https://openalex.org/W2930901495","https://openalex.org/W2794860791","https://openalex.org/W4213215568","https://openalex.org/W2110914223","https://openalex.org/W4311350781","https://openalex.org/W7220030351","https://openalex.org/W2796026385","https://openalex.org/W2965362447","https://openalex.org/W1705881892"],"abstract_inverted_index":{"Lutathera":[0,49],"is":[1,50,76],"a":[2,46],"peptide":[3],"receptor":[4],"radionuclide":[5],"therapy":[6,42],"(PRRT)":[7],"for":[8,52],"neuroendocrine":[9,24,58],"tumors":[10,25],"and":[11,34],"was":[12],"approved":[13],"as":[14],"the":[15,53,63,69,89,93],"first":[16],"PRRT":[17],"drug":[18],"in":[19,21,61,74],"Japan":[20],"2021.":[22],"Although":[23],"are":[26],"often":[27],"less":[28],"aggressive":[29],"than":[30],"other":[31],"highly":[32],"malignant":[33],"invasive":[35],"tumors,":[36],"there":[37],"have":[38],"been":[39],"few":[40],"effective":[41],"options,":[43],"so":[44],"\"Lutathera\"is":[45],"long-awaited":[47],"treatment.":[48],"indicated":[51],"treatment":[54],"of":[55,71,92],"\"somatostatin":[56],"receptor-positive":[57],"tumors\".":[59],"Currently,":[60],"Japan,":[62],"only":[64],"imaging":[65],"method":[66],"to":[67,87],"evaluate":[68],"expression":[70],"somatostatin":[72,97],"receptors":[73],"lesions":[75],"scintigraphy":[77],"using":[78,96],"In-111":[79],"pentetreotide(OctreoScan).":[80],"In":[81],"this":[82],"section,":[83],"we":[84],"would":[85],"like":[86],"introduce":[88],"current":[90],"status":[91],"68Ga-DOTA-SSA":[94],"PET/CT":[95],"analogue(SSA)in":[98],"our":[99],"institution.":[100]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4294127964","counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2022-09-02T00:00:00"}
